The Complete Masked Hypertension
Resource Guide

Comprehensive 2022 AHA position paper defining masked hypertension criteria, prevalence (10–30% of normotensive adults), and cardiovascular risk implications.

Cleveland Clinic cardiologist explains why office BP readings miss 30% of true hypertension cases and what to do about it.

Pooled analysis of 7 cohort studies showing masked hypertension carries 1.7x the cardiovascular risk of sustained hypertension.

Clear comparison of the two opposite BP phenomena — white coat (high at office, normal at home) vs masked (normal at office, high at home).

American College of Cardiology review of risk factors for masked hypertension including diabetes, smoking, and high-normal office BP.

Leading ambulatory BP researcher presents data on how 24-hour monitoring unmasks 15–20% of patients with hidden hypertension.

Foundation resource covering BP categories, what 120/80 means vs 135/85 at home, and why single readings are unreliable.

2023 systematic review finding masked hypertension prevalence ranges from 10–47% depending on population and diagnostic criteria used.

US Preventive Services Task Force Grade A recommendation for out-of-office BP confirmation before diagnosing hypertension.

UK NICE guideline recommending ABPM as gold standard for hypertension diagnosis, explicitly to catch masked hypertension.

FDA-cleared ambulatory blood pressure monitors used in clinical settings for 24-hour BP mapping and masked HTN detection.

Step-by-step walkthrough of ambulatory BP monitoring — device fitting, measurement schedule, sleep readings, and report interpretation.

European guidelines defining masked hypertension as office BP <140/90 but daytime ABPM ≥135/85 or home average ≥135/85.

Calculate 10-year cardiovascular risk — masked hypertension increases ASCVD risk significantly above what office BP alone predicts.

Clinical review identifying high-risk groups: diabetes, chronic kidney disease, smokers, obesity, and high-normal office BP (130–139/85–89).

AHA-validated upper-arm monitor with TruRead averaging, Bluetooth sync, and multi-user support. Stores 200 readings per user.

FDA-cleared, automatically syncs readings to app via Wi-Fi. Color-coded results based on ESH guidelines. Medical-grade accuracy.

AHA/ESH/ISO database of clinically validated home BP monitors. Search by device, protocol, or manufacturer before you buy.

Official AHA protocol: sit quietly 5 min, feet flat, arm supported at heart level, proper cuff size, 2 readings 1 min apart, morning and evening for 7 days.

5-minute video covering the 7 most common errors in home BP measurement that can mask or create false hypertension readings.

FDA-cleared wearable providing continuous cuffless BP monitoring — captures nocturnal hypertension patterns missed by cuff devices.

Compact, travel-friendly upper-arm monitor with irregular heartbeat detection and multi-device sharing for doctor review.

Guide to choosing upper-arm vs wrist monitors, proper cuff sizing, and creating a BP log your doctor can actually use.

Expert consensus on initiating antihypertensive treatment for masked hypertension — current recommendation is treat when confirmed by ABPM.

DASH diet lowers systolic BP 8–14 mmHg. Meal plans, recipes, and the evidence behind the most effective dietary intervention for hypertension.

Why salt sensitivity may be a key driver of masked hypertension and how 24-hour urinary sodium testing reveals true intake.

Evidence-based review: increasing potassium to 3,500–4,700 mg/day lowers systolic BP 3–5 mmHg, especially effective for salt-sensitive individuals.

Systematic review: aerobic exercise 150 min/week reduces systolic BP 5–8 mmHg in hypertensive adults — comparable to first-line medication.

Untreated OSA causes nocturnal hypertension and masked daytime elevation. CPAP treatment can normalize BP in 50% of cases.

Comprehensive clinical reference for physicians — medication selection, follow-up ABPM, and long-term cardiovascular monitoring protocols.

Landmark trial showing targeting SBP <120 reduced CV events 25% vs <140. Critically relevant: SPRINT used automated office BP, not ABPM.

International Database of Ambulatory BP study: masked hypertension associated with 1.7x risk of stroke vs normotensive controls over 10 years.

Search current clinical trials investigating masked hypertension — eligibility criteria, locations, and enrollment status.

International Society of Hypertension keynote on cuffless continuous monitoring and AI-driven masked hypertension detection.

Curated PubMed search query for the most recent peer-reviewed masked hypertension studies, sorted by publication date.

Complete 2017 ACC/AHA hypertension guideline with supplementary updates on ambulatory monitoring and masked hypertension recognition.

Practical guide for implementing ambulatory BP monitoring in primary care to systematically identify masked hypertension patients.